Rubiadin Alleviates Alzheimer’s Disease Pathology via NF-κB Pathway Regulation
Our results provide experimental evidence supporting the preclinical research and future clinical applications of RB, thereby facilitating the development of new drugs for AD clinical therapy.
Authors
- Shanji Nan (ORCID: https://orcid.org/0000-0003-2962-4717)
- Jia Fan (ORCID: https://orcid.org/0000-0002-5078-9623)
- Wanxu Guo
- Jiaqi Pan
- Ying Zhang (ORCID: https://orcid.org/0000-0001-9900-7568)
- Yizhi Zhang (ORCID: https://orcid.org/0000-0002-8667-1256)
Institutions
- Second Affiliated Hospital of Jilin University (CN)
Publication Details
- Journal
- Journal of Integrative Neuroscience
- Published
- 2025-10-31
- DOI
- https://doi.org/10.31083/jin33497
- Primary Topic
- Quinazolinone synthesis and applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Jilin Province
- People's Government of Jilin Province